Autophagy has been shown to be a mechanism of resistance to several chemotherapeutic agents, such as tyrosine kinase inhibitors and monoclonal antibodies targeting the EGFR and VEGFR signaling pathways in multiple solid tumor models including NSCLC. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.